So, Trametinib is a MEK inhibitor used for BRAF V600E/K-mutant melanoma and NSCLC. You can get it in two tablet strengths, 0.5 mg and 2 mg, covered with a film coating. They usually say you take 2 mg per day on an empty stomach.
The tablets come in bottles with 30 tablets in each. What the active part does is block the MEK signaling and hit specific BRAF gene mutations. It’s a grown-up’s medication, and you’ve got to stick to the amount they told you, no more.
Clinical trials have proven it’s effective and safe, and they think it can make a big difference in how people feel. And keep an eye on your liver when you’re on it, ’cause there can be some side effects.
